American agribusiness Archer Daniels Midland (ADM) announced plans Thursday to invest in a new probiotics production facility in Valencia, Spain that will increase the capacity of its Biopolis microbial technologies business to five times its current output.
“Our new Valencia facility will feature leading-edge technology and dramatically enhance our ability to meet fast-growing demand for products and solutions from nature designed to target the microbiome and help improve metabolic health,” Ian Pinner, chief strategy and innovation officer for ADM’s Health & Wellness Division, said in a company release. “Consumers today are increasingly focusing on the foundational role food plays in supporting health and wellness, and our continued investment in these growth areas ensures that ADM is perfectly positioned to meet their needs.”
Once operational, the site will manufacture probiotics and postbiotics using ADM’s technology. The products will be used in skin health, weight management, gut health, oral health, fertility and other applications.
“Consumers today are thinking about the things they eat and drink in new ways,” Pinner said. “They expect food and beverages that are not only delicious, but support health and wellness, come from sustainable ingredients, and are produced by companies that share their values. The growth investments ADM has made in recent years put us in an unparalleled position to meet those changing needs.”
The facility, collocated with ADM’s flavor production plant in Valencia, is expected to start production in 2022.